NCT02246738View on ClinicalTrials.gov

Initial Evaluation of a Telomerase-based Circulating Tumor Cell Assay in Bladder Cancer Cohorts

CompletedOBSERVATIONAL
Enrollment

87

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

August 31, 2018

Study Completion Date

October 31, 2020

Conditions
Urothelial Carcinoma of the Bladder
Interventions
OTHER

Blood Collection

Trial Locations (1)

19104

Abramson Cancer Center of the University of Pennsylvania, Philadelphia

All Listed Sponsors
lead

Abramson Cancer Center at Penn Medicine

OTHER

NCT02246738 - Initial Evaluation of a Telomerase-based Circulating Tumor Cell Assay in Bladder Cancer Cohorts | Biotech Hunter | Biotech Hunter